AMBROXOL Trademark

Trademark Overview


On Tuesday, September 12, 2023, a trademark application was filed for AMBROXOL with the United States Patent and Trademark Office. The USPTO has given the AMBROXOL trademark a serial number of 98176277. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Monday, July 29, 2024. This trademark is owned by Medimex USA Inc. The AMBROXOL trademark is filed in the Pharmaceutical Products category with the following description:

Anti-tussive expectorants
ambroxol

General Information


Serial Number98176277
Word MarkAMBROXOL
Filing DateTuesday, September 12, 2023
Status645 - FINAL REFUSAL - MAILED
Status DateMonday, July 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAnti-tussive expectorants

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 12, 2023
Primary Code005
First Use Anywhere DateFriday, September 1, 2023
First Use In Commerce DateFriday, September 1, 2023

Trademark Owner History


Party NameMedimex USA Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDULUTH, GA 30096

Trademark Events


Event DateEvent Description
Tuesday, May 7, 2024NON-FINAL ACTION E-MAILED
Tuesday, May 7, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 7, 2024ASSIGNED TO EXAMINER
Tuesday, September 12, 2023NEW APPLICATION ENTERED
Sunday, November 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 7, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, July 29, 2024FINAL REFUSAL WRITTEN
Monday, July 29, 2024FINAL REFUSAL E-MAILED

Related Keywords


ambroxol expectorants tussive anti